Suppr超能文献

心脏导管插入术后对比剂诱发的脑病

Contrast-induced encephalopathy following cardiac catheterization.

作者信息

Spina Roberto, Simon Neil, Markus Romesh, Muller David Wm, Kathir Krishna

机构信息

Cardiac Catheterization Laboratories, St Vincent's Hospital, Sydney, New South Wales, Australia.

Department of Neurology, St Vincent's Hospital, Sydney, New South Wales, Australia.

出版信息

Catheter Cardiovasc Interv. 2017 Aug 1;90(2):257-268. doi: 10.1002/ccd.26871. Epub 2016 Nov 29.

Abstract

OBJECTIVES

To describe the epidemiology, pathophysiology, clinical presentation, and management of contrast-induced encephalopathy (CIE) following cardiac catheterization.

BACKGROUND

CIE is an acute, reversible neurological disturbance directly attributable to the intra-arterial administration of iodinated contrast medium.

METHODS

The PubMed database was searched and all cases in the literature were retrieved and reviewed.

RESULTS

52 reports of CIE following cardiac catheterization were found. Encephalopathy, motor and sensory disturbances, vision disturbance, opthalmoplegia, aphasia, and seizures have been reported. Transient cortical blindness is the most commonly reported neurological syndrome, occurring in approximately 50% of cases. The putative mechanism involves disruption of the blood brain barrier and direct neuronal injury. Contrast-induced transient vasoconstriction has also been implicated. Symptoms typically appear within minutes to hours of contrast administration and resolve entirely within 24-48 hr. Risk factors may include hypertension, diabetes mellitus, renal impairment, the administration of large volumes of iodinated contrast, percutaneous coronary intervention or selective angiography of internal mammary grafts, and previous adverse reaction to iodinated contrast. Characteristic findings on cerebral imaging include cortical and sub-cortical contrast enhancement on computed tomography (CT). Imaging findings in CIE may mimic subarachnoid hemorrhage or cerebral ischemia; the Hounsfield scale on CT and the apparent diffusion coefficient on magnetic resonance imaging (MRI) are useful imaging tools in distinguishing these entities. In some cases, brain imaging is normal. Prognosis is excellent with supportive management alone. CIE tends to recur, although re-challenge with iodinated contrast without adverse effects has been documented.

CONCLUSIONS

CIE is an important clinical entity to consider in the differential diagnosis of stroke following cardiac catheterization. Given that prognosis is excellent with supportive management only, physicians should be aware of it, and consider it prior to initiating thrombolysis. © 2016 Wiley Periodicals, Inc.

摘要

目的

描述心脏导管插入术后对比剂诱发脑病(CIE)的流行病学、病理生理学、临床表现及管理。

背景

CIE是一种直接归因于动脉内注射碘化造影剂的急性、可逆性神经功能障碍。

方法

检索PubMed数据库,检索并复习文献中的所有病例。

结果

发现52例心脏导管插入术后CIE的报告。已报告有脑病、运动和感觉障碍、视力障碍、眼肌麻痹、失语和癫痫发作。短暂性皮质盲是最常报告的神经综合征,约50%的病例出现。推测的机制包括血脑屏障破坏和直接神经元损伤。对比剂诱发的短暂血管收缩也与之有关。症状通常在注射对比剂后数分钟至数小时内出现,并在24 - 48小时内完全缓解。危险因素可能包括高血压、糖尿病、肾功能损害、大量碘化造影剂的注射、经皮冠状动脉介入治疗或内乳动脉搭桥的选择性血管造影,以及既往对碘化造影剂的不良反应。脑部影像学的特征性表现包括计算机断层扫描(CT)上的皮质和皮质下对比增强。CIE的影像学表现可能类似于蛛网膜下腔出血或脑缺血;CT上的亨氏单位和磁共振成像(MRI)上的表观扩散系数是区分这些情况的有用影像学工具。在某些情况下,脑部影像学检查正常。仅通过支持性管理,预后良好。CIE有复发倾向,尽管已有再次注射碘化造影剂且无不良反应的记录。

结论

CIE是心脏导管插入术后中风鉴别诊断中需考虑的重要临床实体。鉴于仅通过支持性管理预后良好,医生应了解它,并在启动溶栓治疗前予以考虑。© 2016威利期刊公司

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验